• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人巨细胞病毒对自然杀伤细胞的免疫逃逸:一种四季皆有的病毒?

Human Cytomegalovirus Immune Evasion of Natural Killer Cells: A Virus for All Seasons?

作者信息

Preston Hannah, Casey Rowan, Ferris Elizabeth, Kerr-Jones Lauren, Jones Lauren, Latif Farah, Clement Mathew, Aicheler Rebecca J, Wang Eddie C Y, Stanton Richard J, Fielding Ceri A

机构信息

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

Systems Immunity University Research Institute (SIURI), Cardiff University, Cardiff CF14 4XN, UK.

出版信息

Pathogens. 2025 Jun 24;14(7):629. doi: 10.3390/pathogens14070629.

DOI:10.3390/pathogens14070629
PMID:40732677
Abstract

Human cytomegalovirus (HCMV) is a ubiquitous member of the herpesvirus family, of significant clinical importance, and highly adapted to its host, resulting from millions of years of co-evolution. As a result, the virus systematically subverts almost all aspects of antiviral immune defence to successfully establish a lifelong persistent infection, and in the process, dramatically reshapes the phenotype and function of host immunity to both HCMV and other diseases. Natural killer (NK) cells are a critical component of successful herpesvirus control. Here, we discuss their role in modulating HCMV disease and the multitude of ways that HCMV has evolved to prevent and manipulate this process. We also consider how antibody-dependent cellular cytotoxicity by NK cells directed against HCMV might overcome NK immune evasion mechanisms and be useful therapeutically.

摘要

人巨细胞病毒(HCMV)是疱疹病毒家族中一种普遍存在的病毒,具有重要的临床意义,并且由于数百万年的共同进化,它已高度适应其宿主。因此,该病毒系统性地破坏了抗病毒免疫防御的几乎所有方面,从而成功建立终身持续感染,在此过程中,极大地重塑了宿主对HCMV和其他疾病的免疫表型及功能。自然杀伤(NK)细胞是成功控制疱疹病毒的关键组成部分。在此,我们讨论它们在调节HCMV疾病中的作用,以及HCMV为预防和操纵这一过程而进化出的多种方式。我们还考虑了NK细胞针对HCMV的抗体依赖性细胞毒性如何可能克服NK免疫逃逸机制并在治疗上发挥作用。

相似文献

1
Human Cytomegalovirus Immune Evasion of Natural Killer Cells: A Virus for All Seasons?人巨细胞病毒对自然杀伤细胞的免疫逃逸:一种四季皆有的病毒?
Pathogens. 2025 Jun 24;14(7):629. doi: 10.3390/pathogens14070629.
2
Cracking the Human Cytomegalovirus Code: Trinary Challenges of Latency, Immune Evasion, and Correlates of Protection.破解人类巨细胞病毒密码:潜伏、免疫逃逸及保护相关因素的三重挑战
Iran J Allergy Asthma Immunol. 2025 Jun 26;24(4):403-427.
3
Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses.巨细胞病毒逃避 TRAIL 介导的固有淋巴细胞 1 防御。
J Virol. 2019 Jul 30;93(16). doi: 10.1128/JVI.00617-19. Print 2019 Aug 15.
4
Restriction of Human Cytomegalovirus Infection by Galectin-9.半乳糖凝集素-9抑制人巨细胞病毒感染。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.01746-18. Print 2019 Feb 1.
5
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.多抗原修饰的安卡拉痘苗病毒疫苗载体在小鼠体内诱导针对人巨细胞病毒的体液和细胞免疫应答。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01012-18. Print 2018 Oct 1.
6
Human cytomegalovirus UL23 inhibits immune cell migration and blocks antiviral immune cell responses by reducing the expression of chemokines CCL2 and CCL5.人巨细胞病毒UL23通过降低趋化因子CCL2和CCL5的表达来抑制免疫细胞迁移并阻断抗病毒免疫细胞反应。
Virulence. 2025 Dec;16(1):2500493. doi: 10.1080/21505594.2025.2500493. Epub 2025 Jun 16.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.细胞融合由人巨细胞病毒糖蛋白 B(gB)的融合活性形式诱导,该融合可被针对 gB 外结构域抗原表位 5 的抗体所抑制。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.01276-20.
9
Deletion of the Human Cytomegalovirus US2 to US11 Gene Family Members Impairs the Type-I Interferon Response.删除人类巨细胞病毒US2至US11基因家族成员会损害I型干扰素反应。
Viruses. 2025 Mar 15;17(3):426. doi: 10.3390/v17030426.
10
Cell Biology of Human Cytomegalovirus Latency: Implications for Pathogenesis and Treatment.人巨细胞病毒潜伏的细胞生物学:对发病机制和治疗的启示
Rev Med Virol. 2025 Jul;35(4):e70063. doi: 10.1002/rmv.70063.

本文引用的文献

1
Natural killer cell-based immunotherapy for cancer.基于自然杀伤细胞的癌症免疫疗法。
J Immunol. 2025 Apr 17. doi: 10.1093/jimmun/vkaf036.
2
CD94-driven expansion of highly functional adaptive NKG2C NKG2A CD57 NK cells from CMV healthy donors.来自巨细胞病毒健康供体的由CD94驱动的高功能适应性NKG2C NKG2A CD57 NK细胞的扩增。
Front Immunol. 2025 Jan 31;16:1481745. doi: 10.3389/fimmu.2025.1481745. eCollection 2025.
3
Cytomegalovirus Genetic Diversity and Evolution: Insights into Genotypes and Their Role in Viral Pathogenesis.
巨细胞病毒的遗传多样性与进化:对基因型及其在病毒致病机制中作用的见解
Pathogens. 2025 Jan 9;14(1):50. doi: 10.3390/pathogens14010050.
4
Immunoglobulin-like receptor genotype-associated protection from cytomegalovirus infection after liver transplantation.肝移植后免疫球蛋白样受体基因型相关的巨细胞病毒感染防护
Transpl Immunol. 2025 Feb;88:102171. doi: 10.1016/j.trim.2024.102171. Epub 2024 Dec 27.
5
Auditory and Vestibular Involvement in Congenital Cytomegalovirus Infection.先天性巨细胞病毒感染中的听觉和前庭受累
Pathogens. 2024 Nov 20;13(11):1019. doi: 10.3390/pathogens13111019.
6
In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functions.子宫内人巨细胞病毒感染可扩增介导Fc抗体功能的NK样FcγRIII⁺CD8⁺T细胞。
J Clin Invest. 2024 Nov 12;135(1):e181342. doi: 10.1172/JCI181342.
7
The basic biology of NK cells and its application in tumor immunotherapy.自然杀伤细胞的基础生物学及其在肿瘤免疫治疗中的应用。
Front Immunol. 2024 Aug 16;15:1420205. doi: 10.3389/fimmu.2024.1420205. eCollection 2024.
8
Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission.描述感染孕妇及其婴儿体内自然杀伤细胞特征,并分析其与 CMV 传播的关系。
Viruses. 2024 May 14;16(5):780. doi: 10.3390/v16050780.
9
Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial.信使 RNA 基于的巨细胞病毒疫苗在健康成年人中的安全性和免疫原性:一项 1 期随机临床试验结果。
J Infect Dis. 2024 Sep 23;230(3):e668-e678. doi: 10.1093/infdis/jiae114.
10
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.人巨细胞病毒 mRNA-1647 疫苗候选物比 gB/MF59 疫苗诱导更强和更广泛的中和及抗体依赖性细胞细胞毒性反应。
J Infect Dis. 2024 Aug 16;230(2):455-466. doi: 10.1093/infdis/jiad593.